Genmab A/S (GMAB)

Basic

  • Market Cap

    DKK 143.5B

  • EV

    DKK 116.77B

  • Shares Out

    65.32M

  • Revenue

    DKK 17.02B

  • Employees

    2,132

Margins

  • Gross

    99.41%

  • EBITDA

    39.56%

  • Operating

    37.33%

  • Pre-Tax

    31.56%

  • Net

    25.24%

  • FCF

    33.47%

Returns (5Yr Avg)

  • ROA

    13.99%

  • ROE

    21.15%

  • ROCE

    23.79%

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    DKK 2,647.33

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    DKK 260.69

  • Earnings (Dil)

    DKK 65.16

  • FCF

    DKK 86.42

  • Book Value

    DKK 476.33

Growth (CAGR)

  • Rev 3Yr

    15.57%

  • Rev 5Yr

    43.4%

  • Rev 10Yr

    39.48%

  • Dil EPS 3Yr

    -8.77%

  • Dil EPS 5Yr

    23.22%

  • Dil EPS 10Yr

    92.44%

  • Rev Fwd 2Yr

    15.11%

  • EBITDA Fwd 2Yr

    3.04%

  • EPS Fwd 2Yr

    1.34%

  • EPS LT Growth Est

    15.28%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

3,025.0

5,366.0

10,111.0

8,482.0

14,595.0

17,023.0

Total Revenues % Chg.

27.9%

77.4%

88.4%

-16.1%

72.1%

42.0%

Cost of Goods Sold, Total

—

—

—

—

—

100.0

Gross Profit

3,025.0

5,366.0

10,111.0

8,482.0

14,595.0

16,923.0

Selling General & Admin Expenses, Total

214.0

342.0

661.0

1,283.0

2,676.0

3,284.0

R&D Expenses

1,431.0

2,386.0

3,137.0

4,181.0

5,524.0

7,285.0

Other Operating Expenses, Total

1,645.0

2,728.0

3,798.0

5,464.0

8,200.0

10,569.0

Operating Income

1,380.0

2,638.0

6,313.0

3,018.0

6,395.0

6,354.0

Interest Expense, Total

—

-7.0

-10.0

-13.0

-21.0

-26.0

Interest And Investment Income

63.0

120.0

184.0

197.0

324.0

784.0

Net Interest Expenses

63.0

113.0

174.0

184.0

303.0

758.0

Currency Exchange Gains (Loss)

178.0

99.0

-1,456.0

1,470.0

1,034.0

-1,939.0

Other Non Operating Income (Expenses)

2.0

—

—

—

—

—

EBT, Excl. Unusual Items

1,623.0

2,850.0

5,031.0

4,672.0

7,732.0

5,173.0

Gain (Loss) On Sale Of Investments

-11.0

9.0

873.0

-689.0

-659.0

238.0

Asset Writedown

—

—

—

—

-38.0

-38.0

Other Unusual Items

—

—

—

—

—

—

EBT, Incl. Unusual Items

1,612.0

2,859.0

5,904.0

3,983.0

7,035.0

5,373.0

Income Tax Expense

140.0

693.0

1,146.0

975.0

1,513.0

1,077.0

Earnings From Continuing Operations

1,472.0

2,166.0

4,758.0

3,008.0

5,522.0

4,296.0

Earnings Of Discontinued Operations

—

—

—

—

—

—

Net Income

1,472.0

2,166.0

4,758.0

3,008.0

5,522.0

4,296.0

Net Income to Common Incl Extra Items

1,472.0

2,166.0

4,758.0

3,008.0

5,522.0

4,296.0

Net Income to Common Excl. Extra Items

1,472.0

2,166.0

4,758.0

3,008.0

5,522.0

4,296.0

Total Shares Outstanding

61.5

64.9

65.4

65.4

65.4

65.3

Weighted Avg. Shares Outstanding

61.3

63.0

65.2

65.4

65.4

65.3

Weighted Avg. Shares Outstanding Dil

62.0

63.6

65.9

66.0

66.0

65.9

EPS

24.0

34.4

73.0

46.0

84.5

65.8

EPS Diluted

23.7

34.0

72.2

45.5

83.7

65.2

EBITDA

1,468.0

2,777.0

6,543.0

3,266.0

6,719.0

6,735.0